Baker Ruskinn, a global leader in anaerobic and precision low-oxygen culture solutions for microbiology and cell culture application will be exhibiting at the American Association for Cancer Research (AACR), April 1-5 at the Walter E. Washington Convention Center in Washington DC. Baker will feature our InvivO2 Physiological Cell Culture Workstation at Booth # 2360.
Baker Ruskinn’s InvivO2 line of physiological oxygen, cell culture workstations are designed and built to mimic the physiology of your subject matter, providing the reassurance of precise results under controlled conditions. The InvivO2 workstation is packed with new, innovative features that allow study even the most complex cell interactions under perfect physiological oxygen conditions. Whether replicating the environment of blood vessels or lung tissue, the InvivO2 is the best tool for the job. Easy to use and adaptable to meet users needs, especially for cell culture applications that require carefully controlled oxygen regulation, InvivO2 offers accurate and stable user-defined environmental controls, and direct access to the inner chamber.
Among its many innovative and new standard features, InvivO2 now provides the following:
Baker is pleased to release a new cost comparison tool to review and compare total lifetime costs for biosafety cabinets. Baker’s new Class II Type A2 Biosafety Cabinet Total Cost of Ownership Calculator provides a quick comparison for Baker’s A2 Biosafety Cabinet total cost of ownership against competitors as well as the market average.
AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research. The AACR is the oldest and largest scientific organization in the world focused on every aspect of high-quality, innovative cancer research. Its reputation for scientific breadth and excellence attract the premier researchers in the field.
The Baker Company has long been identified as an industry pioneer in the field of biological safety with an unparalleled passion for helping its customers advance science, discovery and clinical care. The company was first established back in 1949 in response to a growing need to protect hospital workers from infectious diseases and the dangerous process of drug preparation. As solutions for air containment and contamination control have evolved over the years, The Baker Company has been at the forefront of design and innovation, always believing that there are no shortcuts and that there should be no minimum standards applied to the solutions that they supply. In 2011, the company acquired Ruskinn Technology Ltd., one of the world’s leading suppliers of gas-controlled, anaerobic and modified atmosphere workstations for use in medical microbiology, cell biology, cancer research, molecular medicine and stem cell laboratories.